Dr Prashanth Rangan was among the 22 outstanding early-career researchers who were named Pew Scholars in the Biomedical Sciences. Rediff.com's George Joseph reports
The government has ordered monoclonal antibody from Indian Council of Medical Research to treat the child. It is the only available anti-viral treatment for Nipah virus infection, though it has not been clinically proven yet.
The ICMR-National Institute of Virology has been regularly undertaking studies to understand the protective efficacy of COVID-19 vaccines against emerging variants.
The court directed the Kolkata Police to hand over the case diary to the central probe agency by Tuesday evening, and all other documents by 10 am on Wednesday.
Heel pain can be due to plantar fasciitis, Achilles tendonitis or heel pad syndrome, says rediffGURU Dr Shakeeb Ahmed Khan.
After having received the government purchase order for 55 lakh doses, Bharat Biotech shipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram (Vijayawada), Guwahati, Patna, Delhi, Kurukshetra, Bangalore, Pune, Bhubaneswar, Jaipur, Chennai and Lucknow.
He asserted that all efforts are on to contain the spread of the virus in Kerala.
American's National Institute of Health will study a cancer care protocol developed by a Kolkata-based father-son homeopath duo.
Researchers found that India, along with China and Japan, were the three leading countries in Asia in terms of number of new cases and deaths, where they say cancer has become a more significant public health threat with 94 lakh new cases and 56 lakh deaths in 2019.
After identifying the man who was the patient zero or index case of the Nipah virus outbreak in Kerala, the state government on Saturday began looking for the source and place from where he got infected by seeking details of his mobile tower locations.
These include the 25 cases which were announced till Thursday. "All the 29 persons are in physical isolation in health facilities," an official said.
A group of 101 farmers resumed their foot march to Delhi on Sunday to press the Centre for various demands, including a legal guarantee for Minimum Support Price (MSP). However, they were stopped at the barricading by Haryana Police who cited a prohibitory order clamped by the Ambala administration. The farmers have been pressing for various demands, including a legal guarantee for MSP, a farm debt waiver, pension for farmers and farm labourers, no hike in electricity tariff, withdrawal of police cases (against farmers), and "justice" for the victims of the 2021 Lakhimpur Kheri violence. Reinstatement of the Land Acquisition Act, 2013 and compensation to the families of farmers who died during the previous agitation in 2020-21 are also part of their demands.
The National Institute of Virology (NIV) in Pune under the ICMR has isolated the monkeypox virus from the clinical specimen of a patient, which can pave the way for development of diagnostic kits and vaccines against the disease, officials said on Wednesday.
rediffGURU Maxim Emmanuel offers expert advice on how to make an informed career choice.
Union Health Secretary Rajesh Bhushan reviewed the status of passengers coming from the UK to India and found positive in Maharashtra, Karnataka, Telangana, Tamil Nadu, West Bengal, Goa, Punjab, Gujarat and Kerala and their response measures in a meeting held through video conferencing.
'Forcing the development of an indigenous vaccine as a cure for COVID-19, bypassing all health & safety norms, to be announced by PM Modi on Independence Day is fraught with horrendous human costs'
The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists.
The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the United Kingdom and India, respectively.
'They are attacking my wife; they are attacking our 13-month-old daughter. They are saying that I do drugs.' 'I'm giving an open challenge to Mr Nawab Malik and Ms Sana Malik let's go to the labs and let's do the medical test of our family and your family.'
India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.
The Vaccine War leans towards stoking nationalistic fervour, but that shouldn't stop you from watching a film that is solemn about the Indian scientific community's achievement, notes Mayur Sanap.
The doctors treating SARS suspects or patients will use the Defence Research Development Organisation made Nuclear-Biological-Chemical weapon masks.
A visit to the National Science Foundation in Alexandria, Virginia is likely to be the first public engagement of the prime minister, which would be hosted by the First Lady, the White House said on Tuesday.
'...but subjecting our heritage to rigorous evidence-based understanding.'
rediffGURU Mayank Chandel offers advice to students preparing for IIT-JEE and NEET-UG after class 12.
The officials of Indian Council of Medical Research (ICMR) also said there are now 1,065 testing labs in the country -- 768 in the public sector and 297 in private.
The PM directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time. He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately.
I suggest we build a Vigyan Mandir (Temple of Science) with the ambience of a place of worship, so that it becomes a destination for pilgrims. We should embed on its walls bronze plaques describing each scientist mentioned here along with about a dozen of our ancient mathematicians, recommends Professor Kalyan Singhal, historian of science and technology.
"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine," the consent form said.
There are now 1,348 testing labs in the country comprising 914 in the public sector and 434 private labs.
Adults who stay well-hydrated appear to be healthier, develop fewer chronic conditions, such as heart and lung disease, and live longer than those who may not get sufficient fluids.
An Indian-origin woman who was given just months to live a few years ago is celebrating on Monday after doctors say she is showing no evidence of breast cancer following a clinical trial at a UK hospital.
'The lockdown was for both: To flatten the curve or more correctly, delay the rapid spread of COVID outbreak, and to create healthcare infrastructure.'
Times have changed, situations have changed, but the basic nature of superpower geo-politics remains the same and so also India's diplomacy -- call it non-alignment, strategic autonomy or neutrality; it all depends on the time scale, notes Rup Narayan Das.
The researchers believe their findings provide a blueprint for a second-generation, universal vaccine that could prevent infection from current and future SARS-CoV-2 variants, including Omicron.
According to sources, so far only one traveller from Canada having symptoms of monkeypox infection had been isolated.
The Saveetha Institute of Medical and Technical Sciences. The Indian School of Mines, Dhanbad. Vinay Umarji explains why these two universities have made India proud.
Results of an interim study recently published in The Lancet showed that two doses of Covaxin, also known as BBV152, had 77.8 per cent efficacy against symptomatic disease and present no serious safety concerns.
Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances